Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Baker Julian
Over the trailing 90 days, Baker Julian (Other at INCYTE CORP) traded $320.5M of stock (net selling $315.5M) across 12 companies, per 44 SEC Form 4 transactions.
- Role
- Other
- Window
- Trailing 90 days · 44 transactions · CIK 1087939
- Net activity
- −$315.5M ($2.5M bought · $318.0M sold)
By Company (Trailing 90 Days)
| Symbol | Company | Txns | Bought | Sold | Net |
|---|---|---|---|---|---|
| CELC | Celcuity Inc. | 2 | — | $317.8M | −$317.8M |
| INCY | INCYTE CORP | 10 | $2.5M | — | $2.5M |
| ONC | BeOne Medicines Ltd. | 6 | — | $262K | −$262K |
| KOD | Kodiak Sciences Inc. | 2 | — | — | $0 |
| VTVT | vTv Therapeutics Inc. | 2 | — | — | $0 |
| KYMR | Kymera Therapeutics, Inc. | 2 | — | — | $0 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | 4 | — | — | $0 |
| PRLD | Prelude Therapeutics Inc | 2 | — | — | $0 |
| DNLI | Denali Therapeutics Inc. | 4 | — | — | $0 |
| ACAD | ACADIA PHARMACEUTICALS INC | 4 | — | — | $0 |
| KNSA | Kiniksa Pharmaceuticals International, plc | 4 | — | — | $0 |
| TCRX | TScan Therapeutics, Inc. | 2 | — | — | $0 |
Transactions (44)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-07-14 | CELC | Sell | 2.8M | $291.0M | Open market or private sale |
| 2026-07-14 | CELC | Sell | 261.4K | $26.8M | Open market or private sale |
| 2026-06-30 | KOD | Buy | 17.7K | $0 | Grant, award or other acquisition |
| 2026-06-30 | KOD | Buy | 17.7K | $0 | Grant, award or other acquisition |
| 2026-06-30 | INCY | Buy | 400 | $0 | Grant, award or other acquisition |
| 2026-06-30 | INCY | Buy | 400 | $0 | Grant, award or other acquisition |
| 2026-06-26 | VTVT | Buy | 6.0K | $0 | Grant, award or other acquisition |
| 2026-06-26 | VTVT | Buy | 6.0K | $0 | Grant, award or other acquisition |
| 2026-06-24 | KYMR | Buy | 6.1K | $0 | Grant, award or other acquisition |
| 2026-06-24 | KYMR | Buy | 6.1K | $0 | Grant, award or other acquisition |
| 2026-06-17 | MDGL | Buy | 1.5K | $0 | Grant, award or other acquisition |
| 2026-06-17 | MDGL | Buy | 1.5K | $0 | Grant, award or other acquisition |
| 2026-06-17 | MDGL | Buy | 908 | $0 | Grant, award or other acquisition |
| 2026-06-17 | MDGL | Buy | 908 | $0 | Grant, award or other acquisition |
| 2026-06-11 | ONC | Buy | 19.0K | $0 | Grant, award or other acquisition |
| 2026-06-11 | ONC | Buy | 19.0K | $0 | Grant, award or other acquisition |
| 2026-06-09 | PRLD | Buy | 38.0K | $0 | Grant, award or other acquisition |
| 2026-06-09 | PRLD | Buy | 38.0K | $0 | Grant, award or other acquisition |
| 2026-06-08 | INCY | Buy | 6.1K | $0 | Grant, award or other acquisition |
| 2026-06-08 | INCY | Buy | 6.1K | $0 | Grant, award or other acquisition |
| 2026-06-08 | INCY | Buy | 1.6K | $0 | Grant, award or other acquisition |
| 2026-06-08 | INCY | Buy | 1.6K | $0 | Grant, award or other acquisition |
| 2026-06-03 | DNLI | Buy | 6.4K | $0 | Grant, award or other acquisition |
| 2026-06-03 | DNLI | Buy | 6.4K | $0 | Grant, award or other acquisition |
| 2026-06-03 | DNLI | Buy | 19.2K | $0 | Grant, award or other acquisition |
| 2026-06-03 | DNLI | Buy | 19.2K | $0 | Grant, award or other acquisition |
| 2026-05-29 | ACAD | Buy | 32.0K | $0 | Grant, award or other acquisition |
| 2026-05-29 | ACAD | Buy | 32.0K | $0 | Grant, award or other acquisition |
| 2026-05-29 | ACAD | Buy | 18.6K | $0 | Grant, award or other acquisition |
| 2026-05-29 | ACAD | Buy | 18.6K | $0 | Grant, award or other acquisition |
| 2026-05-29 | KNSA | Buy | 36.5K | $0 | Grant, award or other acquisition |
| 2026-05-29 | KNSA | Buy | 36.5K | $0 | Grant, award or other acquisition |
| 2026-05-29 | KNSA | Buy | 6.1K | $0 | Grant, award or other acquisition |
| 2026-05-29 | KNSA | Buy | 6.1K | $0 | Grant, award or other acquisition |
| 2026-05-22 | ONC | Sell | 2.8K | $66K | Open market or private sale |
| 2026-05-22 | ONC | Sell | 2.8K | $66K | Open market or private sale |
| 2026-05-22 | ONC | Sell | 2.7K | $65K | Open market or private sale |
| 2026-05-22 | ONC | Sell | 2.7K | $65K | Open market or private sale |
| 2026-05-20 | TCRX | Buy | 67.0K | $0 | Grant, award or other acquisition |
| 2026-05-20 | TCRX | Buy | 67.0K | $0 | Grant, award or other acquisition |
| 2026-05-08 | INCY | Buy | 15.0K | $1.3M | Exercise or conversion of derivative security |
| 2026-05-08 | INCY | Buy | 15.0K | $1.3M | Exercise or conversion of derivative security |
| 2026-05-08 | INCY | Sell | 15.0K | $0 | Exercise or conversion of derivative security |
| 2026-05-08 | INCY | Sell | 15.0K | $0 | Exercise or conversion of derivative security |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Baker's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.